This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA) for the specialty medication Ozempic (0.25-0.5 mg/dose pen, 3 mL). The $17,871.23 firm fixed price contract has an ultimate completion date of December 20, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not indicate any set-aside requirements, suggesting open competition.
Generated 3/20/25, 10:48 AM